Market Size of Asia Pacific Pharmaceutical Packaging Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Market Size (2024) | USD 41.66 Billion |
Market Size (2029) | USD 58.41 Billion |
CAGR (2024 - 2029) | 6.99 % |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Asia Pacific Pharmaceutical Packaging Market Analysis
The Asia Pacific Pharmaceutical Packaging Market size is estimated at USD 41.66 billion in 2024, and is expected to reach USD 58.41 billion by 2029, growing at a CAGR of 6.99% during the forecast period (2024-2029).
- Pharmaceutical packaging involves the assembly of elements required to enclose, maintain, safeguard, and distribute a secure and effective medicinal product, ensuring that a secure and effective dosage form is accessible at any given time prior to the drug product's expiration date. Appropriate packaging materials are essential for offering tamper-evident security, which aids in deterring the consumption of counterfeit medications. Furthermore, premium packaging materials must comply with rigorous regulatory guidelines.
- The pharmaceutical packaging manufacturers are anticipated to witness significant opportunities in Asia-Pacific, thanks to the increasing investments in the pharmaceutical sector. The rising demand for pharmaceutical drugs and advancements in pharmaceutical technology are directly contributing to the demand for glass bottles, ampules, and other glass packaging solutions. As chronic illnesses continue to rise and the production of COVID-19 vaccine doses remains substantial, the demand for primary packaging is expected to surge, specifically for glass containers.
- Glass packaging is expected to drive the market's growth in the region's pharma packaging sector. Pharmaceutical companies utilize glass containers to package a diverse array of pharmaceutical products, including injectable medications, solid oral pills, liquid formulations, and biologics. The rapid growth of glass packaging is driven by factors such as pharmaceutical manufacturing operations, the rising demand for specialty pharmaceuticals, and the expansion of healthcare infrastructure. This trend is particularly evident in countries like China, India, Japan, and South Korea, where pharmaceutical industries are experiencing significant growth, leading to a surge in demand for glass packaging solutions.
- The plastic bottles industry is projected to experience substantial growth in the coming years. The utilization of PET is steadily increasing in the region, resulting in a weight reduction of up to 90% compared to glass, thus enabling a more cost-effective transportation procedure. Presently, plastic bottles crafted from PET are extensively substituting bulky and delicate glass bottles in the pharmaceutical sector, providing reusable packaging for different liquids. The rising advancements in plastic PET technology for the pharmaceutical industry are anticipated to boost market prospects.
- Additionally, the government's initiatives to enhance the pharmaceutical sector in the area are anticipated to propel the market's expansion. For example, the measures implemented by the Chinese government to expedite the modernization of the nation's healthcare system are projected to stimulate the advancement of the pharmaceutical packaging industry. Moreover, China is proactively improving its pharmaceutical packaging infrastructure and resources while broadening its range of pharmaceutical products, potentially opening up new avenues for pharmaceutical packaging companies.
- China's presence in the global pharmaceutical market has been steadily growing, serving as both a major consumer and a vital component in the global pharmaceutical industry and supply chains. The rapid expansion of the pharmaceutical sector in recent years, driven by scientific and technological advancements, is projected to continue in the future. In December 2023, Danish pharmaceutical firm Novo Nordisk revealed its plan to invest CNY 400 million (USD 59.6 million) in a newly established company in the region by June 2026. These substantial developments are anticipated to drive the demand for pharmaceutical packaging services.
- The packaging industry experienced significant effects due to the COVID-19 pandemic. With a shift in focus toward infectious diseases and vaccines, there was a decrease in successful clinical trials and research and development activities in therapeutic areas like diabetes and hypertension. However, the pharmaceutical industry witnessed a surge in drug demand for various diseases during the pandemic, leading to substantial investments in the packaging business. Fortunately, the pharmaceutical industry quickly recovered by emphasizing the need for safe and hygienic packaging in response to the pandemic.
Asia Pacific Pharmaceutical Packaging Industry Segmentation
Pharmaceutical packaging is the packaging process for pharmaceutical products. The packaging material can be made of several raw materials, such as glass, plastic resins, and metal, and its application is based on the reactivity of the pharmaceutical products to be packaged. The Asia-Pacific pharmaceutical packaging market is segmented by material (plastic, paper and paper board, glass, and aluminum foil), type (ampoules, blister packs, plastic bottles, syringes, vials, and IV fluids), drug delivery mode (oral drug packaging, injectable drug packaging, and pulmonary drug packaging), and country (India, Japan, China, Australia, and Rest of Asia-Pacific). The market sizes and forecasts are provided in terms of value (USD) for all the above segments.
By Material | |
Plastic | |
Paper and Paper Board | |
Glass | |
Aluminum Foil |
By Type | |
Ampoules | |
Blister Packs | |
Plastic Bottles | |
Syringes | |
Vials | |
IV fluids | |
Other Types |
By Drug Delivery Mode | |
Oral Drug packaging | |
Injectable Drug packaging | |
Pulmonary Drug Packaging | |
Other Drug Delivery Modes |
By Country | |
India | |
Japan | |
China | |
Australia | |
Rest of Asia-Pacific |
Asia Pacific Pharmaceutical Packaging Market Size Summary
The Asia-Pacific pharmaceutical packaging market is poised for significant growth, driven by the increasing demand from densely populated countries like India and China. The region's market expansion is supported by advancements in pharmaceutical production and government initiatives aimed at transforming healthcare systems. In China, policies such as the 'Made in China 2025' plan are fostering innovation in biotech and pharmaceutical packaging, creating new opportunities for market players. The shift towards sustainable packaging solutions and technological advancements, such as the development of lightweight and compact packaging designs, are further propelling market growth. The COVID-19 pandemic highlighted the importance of efficient and hygienic packaging, leading to a rapid recovery and increased demand for safe packaging solutions. Additionally, geopolitical events like the Russia-Ukraine war have impacted the packaging ecosystem, emphasizing the need for resilient supply chains.
The market is characterized by a competitive landscape with key players like Amcor Ltd., West Pharmaceutical Services, and Gerresheimer AG actively expanding their production capabilities and introducing innovative products. The preference for glass packaging, due to its sustainability and safety features, is driving the demand for glass containers in the region. The rising need for injectable pharmaceuticals and stringent quality regulations are further boosting the adoption of glass packaging solutions. Investments in research and development, along with collaborations between companies, are expected to enhance packaging technologies and meet the growing demand for environmentally friendly and cost-effective solutions. The Asia-Pacific pharmaceutical packaging market is set to benefit from these trends, with increasing investments and strategic partnerships supporting its growth trajectory.
Asia Pacific Pharmaceutical Packaging Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Industry Value Chain Analysis
-
1.3 Industry Attractiveness - Porter's Five Forces Analysis
-
1.3.1 Bargaining Power of Supplier
-
1.3.2 Bargaining Power of Consumers
-
1.3.3 Threat of New Entrants
-
1.3.4 Threat of Substitute Products
-
1.3.5 Intensity of Competitive Rivalry
-
-
1.4 Market Drivers
-
1.4.1 Increasing Adoption of Pharmaceutical Packaging in Emerging Economies
-
-
1.5 Market Restraints
-
1.5.1 Fluctuations in Raw Material Cost
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Material
-
2.1.1 Plastic
-
2.1.2 Paper and Paper Board
-
2.1.3 Glass
-
2.1.4 Aluminum Foil
-
-
2.2 By Type
-
2.2.1 Ampoules
-
2.2.2 Blister Packs
-
2.2.3 Plastic Bottles
-
2.2.4 Syringes
-
2.2.5 Vials
-
2.2.6 IV fluids
-
2.2.7 Other Types
-
-
2.3 By Drug Delivery Mode
-
2.3.1 Oral Drug packaging
-
2.3.2 Injectable Drug packaging
-
2.3.3 Pulmonary Drug Packaging
-
2.3.4 Other Drug Delivery Modes
-
-
2.4 By Country
-
2.4.1 India
-
2.4.2 Japan
-
2.4.3 China
-
2.4.4 Australia
-
2.4.5 Rest of Asia-Pacific
-
-
Asia Pacific Pharmaceutical Packaging Market Size FAQs
How big is the Asia Pacific Pharmaceutical Packaging Market?
The Asia Pacific Pharmaceutical Packaging Market size is expected to reach USD 41.66 billion in 2024 and grow at a CAGR of 6.99% to reach USD 58.41 billion by 2029.
What is the current Asia Pacific Pharmaceutical Packaging Market size?
In 2024, the Asia Pacific Pharmaceutical Packaging Market size is expected to reach USD 41.66 billion.